🟢 Neumora Therapeutics is trading 7% up in pre-market

Neumora Therapeutics is trading at $0.74, up 6.98%, with no clear company-specific catalyst identified for the September 29 move.

• The latest listed company releases predate this session.
• Provided index context shows modest gains, while overnight headlines describe cautious trading amid higher oil prices and Treasury yields; these conditions do not establish a direct reason for the stock’s rise.